Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jmv.26165 http://scihub22266oqcxt.onion/10.1002/jmv.26165 32530507!7307112!32530507     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Med+Virol 2020 ; 92 (11): 2866-2869 Nephropedia Template TP {{tp|p=32530507|t=2020. Can steroids reverse the severe COVID-19 induced "cytokine storm"?|pdf=|usr=}}{{32530507}} gab.com Text Can steroids reverse the severe COVID-19 induced "cytokine storm" JO: J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32530507 #FOAvip Severe coronavirus disease (COVID-19) is characterized by an excessive proinflammatory cytokine storm, resulting in acute lung injury and development of acute respiratory distress syndrome (ARDS). The role of corticosteroids is controversial in severe COVID-19 pneumonia and associated hyper-inflammatory syndrome. We reported a case series of six consecutive COVID-19 patients with severe pneumonia, ARDS and laboratory indices of hyper-inflammatory syndrome. All patients were treated early with a short course of corticosteroids, and clinical outcomes were compared before and after corticosteroids administration. All patients evaded intubation and intensive care admission, ARDS resolved within 11.8 days (median), viral clearance was achieved in four patients within 17.2 days (median), and all patients were discharged from the hospital in 16.8 days (median). Early administration of short course corticosteroids improves clinical outcome of patients with severe COVID-19 pneumonia and evidence of immune hyperreactivity. Twit Text FOAVip Can steroids reverse the severe COVID-19 induced "cytokine storm" ????J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32530507 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32530507 #FOAvip English Wikipedia <ref>{{Cite pmid|32530507}}</ref> Can steroids reverse the severe COVID-19 induced "cytokine storm"? #MMPMID32530507 Kolilekas L; Loverdos K; Giannakaki S; Vlassi L; Levounets A; Zervas E; Gaga M J Med Virol 2020[Nov]; 92 (11): 2866-2869 PMID32530507show ga Severe coronavirus disease (COVID-19) is characterized by an excessive proinflammatory cytokine storm, resulting in acute lung injury and development of acute respiratory distress syndrome (ARDS). The role of corticosteroids is controversial in severe COVID-19 pneumonia and associated hyper-inflammatory syndrome. We reported a case series of six consecutive COVID-19 patients with severe pneumonia, ARDS and laboratory indices of hyper-inflammatory syndrome. All patients were treated early with a short course of corticosteroids, and clinical outcomes were compared before and after corticosteroids administration. All patients evaded intubation and intensive care admission, ARDS resolved within 11.8 days (median), viral clearance was achieved in four patients within 17.2 days (median), and all patients were discharged from the hospital in 16.8 days (median). Early administration of short course corticosteroids improves clinical outcome of patients with severe COVID-19 pneumonia and evidence of immune hyperreactivity. |*COVID-19 Drug Treatment[MESH] |COVID-19/complications[MESH] |Cytokine Release Syndrome/*drug therapy/virology[MESH] |Drug Administration Schedule[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Prospective Studies[MESH] |Registries[MESH] |Steroids/*therapeutic use[MESH] |Time Factors[MESH]Can steroids reverse the severe COVID-19 induced "cytokine storm"?(epmc).pdf DeepDyve Pubget Overpricing